Who is sponsoring NCT04132154?

NCT04132154 is sponsored by St. Marien-Hospital Düren.

What drugs are being tested in NCT04132154?

Interventions in NCT04132154: Convective Forced-Air Active Warming.

What condition does NCT04132154 study?

NCT04132154 studies Inadvertent Perioperative Hypothermia.

Is NCT04132154 still recruiting?

NCT04132154 is currently completed. Last updated 21 May 2021.

Last reviewed 2021-05-21 · How we verify

NCT04132154

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prevention of Hypothermia During Caesarean Section: Continuous Core Temperature Monitoring With Zero-heat-flux

Completed Last updated 21 May 2021

What this trial tests

trial testing Convective Forced-Air Active Warming in Inadvertent Perioperative Hypothermia in 111 participants. Completed in 23 June 2020.

Timeline

15 October 2019

Primary endpoint
23 June 2020

23 June 2020

Quick facts

Lead sponsor	St. Marien-Hospital Düren
Status	Completed
Study type	OBSERVATIONAL
Enrollment	111
Start date	15 October 2019
Primary completion	23 June 2020
Estimated completion	23 June 2020
Sites	1 location across Germany

Drugs / interventions tested

Convective Forced-Air Active Warming

Conditions studied

Inadvertent Perioperative Hypothermia — all drugs for Inadvertent Perioperative Hypothermia →

Sponsor

St. Marien-Hospital Düren

Who can join

Adults 18 to 45, female only, with Inadvertent Perioperative Hypothermia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Nowadays, caesarean sections account for about 7% of all surgical procedures worldwide. Over 30% of the patients undergoing a caesarean section experience a fall of the body core temperature under 36°C during the procedure. Following a retrospective cohort design, this study aims to examine the magnitude of hypothermia in the parturient and newborn population as well as the impact and efficiency of forced-air warming on preventing it. The researchers plan to conduct a retrospective analysis of the caesarean section treatment protocol at our institution over a period of 5 months including approximately 300 patients who underwent both elective and emergency caesarean sections.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Forced-air warming and continuous core temperature monitoring with zero-heat-flux thermometry during cesarean section: a retrospective observational cohort study.
Marin L, Höcker J, Esser A, Terhorst R, et al · · 2022 · cited 6× · PMID 34848308 · DOI 10.1016/j.bjane.2021.10.007

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04132154 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by St. Marien-Hospital Düren
Last refreshed: 21 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04132154.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing